Analyst consensus rating
Prestige Consumer Healthcare Analyst Rating: Buy
Direct answer
Prestige Consumer Healthcare's consensus rating is Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $66.20.
Forecast evidence checked November 18, 2026.
Get free Prestige Consumer Healthcare email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $48.22
- Average price target
- $66.20
- High price target
- $75.00
- Low price target
- $51.00
- Low target gap
- +5.8%
- Target upside
- +37.3%
- High target gap
- +55.5%
- Target range width
- 49.8%
- Consensus rating
- Buy
- Analysts
- 5
- Evidence date
- November 18, 2026
- Valid through
- November 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Prestige Consumer Healthcare?
Prestige Consumer Healthcare has a verified Buy consensus. The same dataset has an average price target of $66.20.
How far are Prestige Consumer Healthcare's low and high targets from the recorded price?
The low target implies +5.8%, while the high target implies +55.5%.
How many analysts are included in Prestige Consumer Healthcare's consensus?
The verified consensus includes 5 analysts.
How is Prestige Consumer Healthcare's target upside or downside calculated?
The average target of $66.20 is divided by the recorded price of $48.22, then one is subtracted to produce +37.3%. This does not guarantee a future return.
When was Prestige Consumer Healthcare's analyst forecast verified?
The data was verified on 2026-11-18. The dataset is valid through 2026-11-25.